Viral infections in pregnancy

Minerva Ginecologica

Volumn 59, Issue 2, 2007, Pages 159-174

  Haun, L ^a   Kwan, N ^a   Hollier, L M ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Cytomegalovirus; Hepatitis; Herpes simplex virus; Parvovirus; Pregnancy; Varicella zoster virus

Indexed keywords

ACICLOVIR; CHICKENPOX VACCINE; GANCICLOVIR; IMMUNOGLOBULIN; LAMIVUDINE; VALACICLOVIR;

BLOOD TOXICITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CYTOMEGALOVIRUS INFECTION; DELTA AGENT HEPATITIS; DIAGNOSTIC PROCEDURE; EPSTEIN BARR VIRUS; FETUS DISEASE; FETUS HYDROPS; HEPATITIS A; HEPATITIS B; HEPATITIS C; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HERPES ZOSTER; HUMAN; META ANALYSIS; NEUTROPENIA; PARVOVIRUS; PATHOGENESIS; PREGNANCY; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; SYSTEMATIC REVIEW; VARICELLA ZOSTER VIRUS; VIRUS INFECTION; VIRUS TRANSMISSION;

CYTOMEGALOVIRUS INFECTIONS; DISEASE TRANSMISSION, VERTICAL; FEMALE; HEPATITIS, VIRAL, HUMAN; HERPES SIMPLEX; HERPES ZOSTER; HUMANS; INFANT, NEWBORN; PARVOVIRIDAE INFECTIONS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 34447527708     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (139)

1. Langenberg AGM, Corey L, Ashley RL, Leong WP, Straus SE. A prospective study of new infections with herpes simplex virus type 1 and type 2. N Engl J Med 1999;341:1432-8.
2. Fleming DT, McQuillan GM, Johnson RE, Nahmias AJ, Aral SO, Lee FK. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997;337:1005-11.
3. Wutzler P, Doerr HW, Farber I, Eichhorn U, Helbig B, Sauerbrei A et al. Seroprevalence of herpes simplex virus type 1 and type 2 in selected German populations: revelance for the incidence of genital herpes. J Med Virol 2000;61:201-7.
4. Cunningham AL, Taylor R, Taylor J, Marks C, Shaw J, Mindel A. Prevalence of infection with herpes simplex virus types 1 and 2 in Australia: a nationwide population based survey. Sex Transm Infect 2006;82:164-8.
5. Cowan FM, French RS, Mayaud P, Gopal R, Robinson NJ, de Oliveira SA et al. Seroepidemiological study of herpes simplex virus types 1 and 2 in Brazil, Estonia, India, Morocco, and Sri Lanka. Sex Transm Infect 2004;79:286-90.
6. Lafferty WE, Downey L, Celum C, Wald A. Herpes simplex virus type 1 as a cause of genital herpes: impact on surveillance and prevention. J Infect Dis 2000;181:1454-7.
7. Nilsen A, Myrmel H. Changing trends in genital herpes simplex virus infection in Bergen, Norway. Acta Obstet Gynecol Scand 2000;79:693-6.
8. Roberts CM, Pfister JR, Spear SJ. Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students. Sex Transm Dis 2003;30:797-800.
9. Brown ZA, Selke S, Zeh J, Kopelman J, Maslow A, Ashley RL et al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med 1997;337:509-15.
10. Gardella C, Brown Z, Wald A, Selke S, Zeh J, Morrow RA, Corey L. Risk factors for herpes simplex virus transmission to pregnant women: a couples study. Am J Obstet Gynecol 2005;193:1891-9.
11. Sheffield JS, Hill JB, Hollier LM, Laibl VR, Roberts S, Sanchez PJ et al. Valacyclovir prophylaxis to prevent recurrent herpes at delivery: a randomized clinical trial. Obstet Gynecol 2006;108:141-7.
12. Watts DH, Brown ZA, Money D, Selke S, Huang ML, Sacks SL et al. A double-blind, randomized, placebo-controlled trial of acyclovir in late pregnancy for the reduction of herpes simplex virus shedding and cesarean delivery. Am J Obstet Gynecol 2003;188:836-43.
13. Hutto C, Arvin A, Jacobs R, Steele R, Stagno S, Lyrene R et al. Intrauterine herpes simplex virus infections. J Pediatr 1987;110:97-101.
14. Ratanajamit C, Vinther Skriver M, Jepsen P, Chongsuvivatwong V, Olsen J, Sorensen HT: Adverse pregnancy outcomes in women exposed to acyclovir during pregnancy: a population-based observational study. Scand J Infect Dis 2003;35:255-9.
15. Brown ZA, Wald A, Morrow RA, Selke S, Zeh J, Corey L. Effect of serologic status and Cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA. 2003;289:203-9.
16. Brown ZA, Benedetti J, Ashley R, Burchett S, Selke S, Berry S et al. Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N Engl J Med 1991;324:1247.
17. Whitley RJ, Corey L, Arvin A, Lakeman FD, Sumaya CV, Wright PF et al. Changing presentation of herpes simplex virus infection in neonates. J Infect Dis 1988;158:109-116.
18. Whitley R, Arvin A, Prober C, Burchett S, Corey L, Powell D, et al. A controlled trial comparing vidarabine with acyclovir in neonates with herpes simplex virus infection. N Engl J Med 1991;324:444-9.
19. Kimberlin DW, Lin CY, Jacobs RF, Powell DA, Corey L, Gruber WC et al. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics 2001;108:230-8.
20. Centers for Disease Control and Prevention. Sexually Transmitted Diseases Treatment Guidelines 2006. MMWR 2006;55(No. RR-11):16-20.
21. Slomka MJ, Emery L, Munday PE, Moulsdale M, Brown DWG. A comparison of PCR with virus isolation and direct antigen detection for diagnosis of typing of genital herpes. J Med Virol 1998;55:177-83.
22. Wald A, Huang ML, Carrell D, Selke S, Corey L. Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture. J Infect Dis 2003;188:1345-51.
23. Moseley RC, Corey L, Benjamin D, Winter C, Remington ML. Comparison of viral isolation, direct immunofluorescence, and indirect immunoperoxidase techniques for detection of genital herpes simplex virus infection. J Clin Microbiol 1981;13:913-8.
24. Cone RW, Hobson AC, Palmer J, Remington M, Corey L. Extended duration of herpes simplex virus DNA in genital lesions detected by the polymerase chain reaction. J Infect Dis 1991;164:757-60.
25. Cone R, Hobson A, Brown Z, Ashley R, Berry S, Winter C, et al. Frequent detection of genital herpes simplex virus DNA by polymerase chain reaction among pregnant women. JAMA 1994;272:792-6.
26. Morrow RA, Friedrich D, Meier A, Corey L. Use of "Biokit HSV-2 Rapid Assay" to improve the positive predictive value of Focus HerpeSelect HSV-2 ELISA. BMC Infectious Diseases 2005;5:84-90.
27. Turner KR, Wong EH, Kent CK, Klausner JD. Serologic herpes testing the in the real world. Validation of new type-specific serologic herpes simplex virus tests in a public health laboratory. Sex Transm Dis 2002;29:422-25.
28. Wald A, Ericsson M, Krantz E, Selke S, Corey L. Oral shedding of herpes simplex virus type 2. Sex Transm Infect. 2004;80:272-6 (Level II-2).
29. Centers for Disease Control and Prevention. 2002 Sexually Transmitted Disease Treatment Guidelines. MMWR 2002;51(RR-6):1.
30. Centers for Disease Control and Prevention. Pregnancy outcomes following systemic acyclovir exposure. June 1, 1984-June 30, 1993. MMWR Morb Mortal Wkly Rep 1993;42:806-9.
31. Bryson YJ, Dillon M, Lovett M, Acuna G, Taylor S, Cherry JD et al. Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. A randomized double-blind controlled trial in normal subjects. N Engl J Med 1983;308:916-21.
32. Sheffield JS, Hollier LM, Hill JB, Stuart GS, Wendel GD. Acyclovir prophylaxis to prevent herpes simplex virus recurrence at delivery: a systematic review. Obstet Gynecol 2003;102:1396-403-
33. Andrews WW, Kimberlin DF, Whitley R, Cliver S, Ramsey PS, Deeter R. Valacyclovir therapy to reduce recurrent genital herpes in pregnant women. Am J Obstet Gynecol 2006;194:774-81.
34. Peng J, Krause PJ, Kresch M. Neonatal herpes simplex virus infection after cesarean section with intact amniotic membranes. J Perinatol 1996;16:397-9.
35. Roberts SW, Cox SM, Dax J, Wendel GD Jr, Leveno KJ. Genital herpes during pregnancy: no lesions, no cesarean. Obstet Gynecol 1995;85:261-4.
36. Nahmias AJ, Josey WE, Naib ZM, Freeman MG, Fernandez RJ, Wheeler JH. Perinatal risk associated with maternal genital herpes simplex virus infection. Am J Obstet Gynecol 1971;110:825-37.
37. Sever JA, White LR. Intrauterine viral infections. Ann Rev Med 1969;19:471.
38. Tseng HF, Tan HF, Chang CK. Use of National Health Insurance database to evaluate the impact of public varicella vaccination program on burden of varicella in Taiwan. Vaccine. 2006;24:5341-8.
39. Centers for Disease Control and Prevention: Recommendations of the immunization practices advisory committee: Varicella-zoster immune globulin for the prevention of chicken pox. MMWR 1984;33:84.
40. th Ed, National Immunization Program, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services. January 2005.
41. Smego RA, Asperilla MO. Use of acyclovir for varicella pneumonia during pregnancy. Obstet Gynecol 1991;78:1112.
42. Harger JH, Ernest JM, Thurnau GR, Moawad A, Thom E, Landon MB et al. Frequency of congenital varicella syndrome in a prospective cohort of 347 pregnant women. Obstet Gynecol 2002;100:260-5.
43. Harger JH, Ernest JM, Thurnau GR, Moawad A, Momirova V, Landon MB et al. Risk factors and outcome of varicella-zoster virus pneumonia in pregnant women. J Infect Dis 2002;185:422-7.
44. LaForet EG, Lynch CL. Multiple congenital defects following maternal varicella. N Engl J Med 1947;236:534.
45. Preblud SR, Cochi SL, Orenstein WA. Varicella-zoster infection in pregnancy. N Engl J Med 1986; 315:1416.
46. Enders G, Miller E, Cradock-Watson J, Bolley I, Ridehalgh M. Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet 1994;343:1548-50.
47. Miller E, Cradock-Watson JE, Ridehalgh MK. Outcome of newborn babies given anti-varicella-zoster immunogobulin after perinatal infection with varicella-zoster virus. Lancet 1989; ii(8659)371-3.
48. McGregor JA, Mark S, Crawford GP, Levin MJ. Varicella zoster antibody testing in the care of pregnant woman exposed to varicella. Am J Obstet Gynecol 1987;157:281-4.
49. Puchhammer-Stöckl E, Kunz C, Wagner C, Enders G. Detection of varicella virus (VZV) DNA in fetal tissue by polymerase chain reaction. J Perinatol Med 1994;22:65-9.
50. Verstraelen H, Vanzieleghem B, Defoort P, Vanhaesebrouck P, Temmerman M. Prenatal ultrasound and magnetic resonance imaging in fetal varicella syndrome: correlation with pathology findings. Prenat Diagn 2003;23:705-9.
51. Yaron Y, Hassan S, Geva E, Kupferminc MJ, Yavetz H, Evans MI. Evaluation of fetal echogenic bowel in the second trimester. Fetal Diagn Ther 1999;14:176-80.
52. Pretorius DH, Hayward I, Jones KL, Stamm E. Sonographic evaluation of pregnancies with maternal varicella infection. J Ultrasound Med 1992;11:45-63.
53. Centers for Disease Control and Prevention. A new product (VariZIG) for postexposure prophylaxis of varicella available under an investigational new drug application expanded access protocol. MMWR Morb Mortal Wkly Rep 2006;55:209-10.
54. Enders G. Management of varicella-zoster contact and infection in pregnancy using a standardized varicella-zoster ELISA test. Postgrad Med J 1985;61(S4):23.
55. Wallace MR, Bowler WA, Murray NB, Brodine SK, Oldfield EC. Treatment of adult varicella with oral acyclovir. Ann Intern Med 1992;117:358-63.
56. Ogilvie MM. Antiviral prophylaxis and treatment in chickenpox. A review prepared for me UK advisory Group on Chickenpox on behalf of the British Society for the Study of Infection. J Infect 1998;36(Suppl 1):31-8.
57. Kesson AM, Grimwood K, Burgess MA, Ferson MJ, Gilbert GL, Hogg G, et al. Acyclovir for the prevention and treatment of varicella zoster in children, adolescents and pregnancy. J Paediatr Child Health 1996;32:211-7.
58. Ramin SM, Gilstrap LC. Varicella zoster in pregnancy. In: Pastorek JG, editor. Obstetric and Gynecologic Infectious Disease. New York: Raven Press; 1994.p343.
59. Clark GP, Dobson PM, Thickett A, Turner NM. Chicken pox pneumonia, its complications and management: A report of three cases, including the use of extracorporeal membrane oxygenation. Anaesthesia 1991 ;46: 376-80.
60. Cox SM, Cunningham FG, Luby J. Management of varicella pneumonia complicating pregnancy. Am J Perinatol 1990;7:300-1.
61. Moomaw MD, Cornea P, Rathbun RC, Wendel KA. Review of antiviral therapy for herpes labialis, genital herpes and herpes zoster. Expert Rev Anti Infect Ther 2003;1:283-95.
62. American Academy of Pediatrics. Varicella zoster infections. In: Pickering LK, ed. Red Book: 2003 Report of the Committee on Infectious Diseases. 26th edition. Elk Grove Village, IL: American Academy of Pediatrics; 2003.p.672-86.
63. Hanngren K, Grandien M, Granstrom G. Effect of zoster immunoglobulin for varicella prophylaxis in the newborn. Scand J Infect Dis 1985;17:343-7.
64. Centers for Disease Control and Prevention. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices. MMWR 1996;45(RR-11):1-25.
65. Peckham CS. Cytomegalovirus infection: Congenital and neonatal disease. Scand J Infect Suppl 1991:80;82-87.
66. Klemola E, Kaarianinen L. Cytomegalovirus as a possible cause of a disease resembling infectious mononucleosis. BMJ 1965;2:1099.
67. Revello MG, Gerna G. Diagnosis and management of Human Cytomegalovirus infection in the mother fetus, and newborn infant. Clin Microbiol Rev 2002;15:680-715.
68. rd edition. Philadelphia: Lippincott-Raven; 1996.p.2493.
69. Stara SAS, Dollard SC, Radford KW, Fanders WD, Pass RF, Cannon MJ. Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. Clin Infect Dis 2006;43:1143-51.
70. Tookey PA, Ades AE, Peckham CS. Cytomegalovirus prevalence in pregnant women: the influence of parity. Arch Dis Child 1992;67:779-83.
71. Hecker M, Qiu D, Marquardt K, Bein G, Hackstein H. Continuous cytomegalovirus seroconversion in a large group of healthy blood donors. Vox Sang 2004;86:41-4.
72. Griffiths PD, Baboonian C, Rutter D, Peckham C. Congenital and maternal cytomegalovirus infection in a London population. Br J Obstet Gynaecol 1991;98:135-40.
73. Lamy M, Mulongo K, Gadisseux J, Lyon G, Gaudy V, Van Lierde M. Prenatal diagnosis of fetal cytomegalovirus infection. Am J Obstet Gynecol 1992;166(1 pt 1):91-4.
74. Stagno S, Pass R, Cloud G, Britt WJ, Henderson RE, Walton PD. Primary cytomegalovirus infection in pregnancy: Incidence, transmission to fetus, and clinical outcome. JAMA 1986;256:1904-8.
75. Griffiths P, Baboonian C, Ashby D. The demographic characteristics of pregnant women infected with cytomegalovirus. Int J Epidemiol 1985;14:447-52.
76. Yow MD, Williamson DW, Leeds LJ, Thompson P, Woodward RM, Walmus BF et al. Epidemiologic characteristics of cytomegalovirus infection in mothers and their infants. Am J Obstet Gynecol 1988;158:1189-95.
77. Pass RF, Boppana S. Cytomegalovirus. In: Jeffries DJ, Hudson Cn eds. Viral infections in obstetrics and gynecology. New York: Arnold; 1999.p.35-56.
78. Gaytant MA, Steegers EA, Semmekrot BA, Merkus HM, Galama JM. Congenital cytomegalovirus infection: review of the epidemiology and outcome. Obset Gynecol Surv 2002;57:245-56.
79. Barbi M, Binda S, Caroppo S, Calvario A, Germinario C, Bozzi A et al. Multicity Italian study of congenital cytomegalovirus infection. Pediatr Infect Dis J 2006;25:156-9.
80. Goff E, Griffith B, Booss J. Delayed amplification of cytomegalovirus infection in the placenta and maternal tissues during late gestation. Am J Obstet Gynecol 1987;156:1265-70.
81. Demmler GJ. Infectious Diseases Society America and Centers for Disease Control. Summary of a workshop on surveillance for congenital cytomegalovirus disease. Rev Infect Dis 1991;13:315-29.
82. Boppana SB, Rivera LB, Fowler KB, Mach M, Britt WJ. Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N Engl J Med 2001;344:1366-71.
83. Fowler KB, Stagno S, Pass RF, Britt WJ, Boll TJ, Alford CA. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med 1992;326:663.
84. Reynolds DW, Stagno S, Stubbs KG, Dahle AJ, Livingston MM, Saxon SS et al. Inapparent congenital cytomegalovirus infection with elevated cord IgM levels: Causal relationship with auditory and mental deficiency. N Engl J Med 1974;290:291-6.
85. Enders M, Weidner A, Zoellner I, Searle K, Enders G. Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases. Prenat Diagn 2004;24:513-8.
86. Maine GT, Strieker R, Schuler M, Spesard J, Brojanac S, Iriarte B et al. Development and clinical evaluation of a recombinant-antigen-based cytomegalovirus immunoglobulin M automated immunoassay using the Abbott AxSYM analyzer. J Clin Microbiol 2000;38:1476-81.
87. Bodeus M, Goubau P. Predictive value of maternal-IgG avidity for congenital human cytomegalovirus infection. J Clin Virol 1999;12:3-8.
88. Grangeot-Keros L, Mayaux MJ, Lebon P, Freymuth F, Eugene G, Strieker R et al. Value of cytomegalovirus (CMV) IgG avidity index for the diagnosis of primary CMV infection in pregnant women. J Infect Dis 1997;175:944-6.
89. Lazzarotto T, Ripalti A, Bergamini G, Battista MC, Spezzacatena P, Campanini F et al. Prenatal diagnosis of congenital cytomegalovirus infection. J Clin Microbiol 1998;36:3540-3544.
90. Donner C, Liesnard C, Content J, Busine A, Aderca J, Rodesch F. Prenatal diagnosis of 52 pregnancies at risk for congenital cytomegalovirus infection. Obstet Gynecol 1993;82(4 pt 1):481-6.
91. Nicolini U, Kustermann A, Tassis B, Fogliani R, Galimberti A, Percivalle E et al. Prenatal diagnosis of congenital human cytomegalovirus infection. Prenatal Diagnosis 1994;14:903-6.
92. Revello MG, Gema G. Diagnosis and implications of human cytomegalovirus infection in pregnancy. Fet Matern Med Rev 1999;11:117-34.
93. Schleiss MR, Stroup G, Pororzelski K, McGregor A. Protection against congenital cytomegalovirus (CMV) diseae, conferred by a replication-disabled, bacterial artificial chromosome (BAC)-based DNA vaccine. Vaccine 2006;24:6175-86.
94. Schleiss MR, Bourne N, Bernstein DI. Preconception vaccination with a glycoprotein B (gB) DNA vaccine protects against cytomegalovirus (CMV) transmission in the guinea pig model of congenital CMV infection. J Infect Dis 2003;188:1868-74.
95. Anderson MJ, Jones SE, Fisher-Hoch SP, Lewis E, Hall SM, Bartlett CL et al. Human parvovirus, the cause of erythema infectiosum (fifth disease)? Lancet 1983;1:1378.
96. Enders M, Weidner A, Enders G. Current epidemiologic aspects of human parvovirus B19 infection during pregnancy and childhood in western part of Germany. Epidemiol Infect 2006;doi:10.1017/S095026880600731;1-7.
97. Jensen IP, Thorsen P, Jeune B, Møller BR, Vestergaard BF. An epidemic of parvovirus B19 in a population of 3596 pregnant women: a study of sociodemographic and medical risk factors. Br J Obstet Gynaecol 2000;107:637-43.
98. Valeur-Jensen AK, Pedersen CB, Westergaard T, Jensen IP, Lebech M, Andersen PK et al. Risk factors for parvovirus B19 in pregnancy. JAMA 1999;281:1099-105-
99. Brown KE, Anderson SM, Young NS. Erythrocyte P antigen: cellular receptor for B 19 parvovirus. Science 1993;262:114-7.
100. Jordan JA, Deloia JA. Globoside expression within the human placenta. Placenta 1999;20:103-8.
101. Torok TJ, Wang QY, Gary GW Jr, Yang CF, Finch TM, Anderson LJ. Prenatal diagnosis of intrauterine infections with parvovirus B19 by the polymerase chain reaction. Clin Infect Dis 1992;14:149-55.
102. Harger JH, Adler SP, Kock WC, Harger GF. Prospective evaluation of 618 pregnant women exposed to parvovirus B19: Risks and symptoms. Obstet Gynecol 1998;91:412-20.
103. Crane J. Parvovirus B 19 infection in pregnancy. J Obstet Gynaecol Can 2002;24:727-43.
104. Koch WC, Harger JH, Barnstein B, Adler SP. Serologic and virologic evidence for frequent intrauterine transmission of human parvovirus B19 with a primary maternal infection during pregnancy. Pediatr Infect Dis J 1998;17:489-94.
105. de Jong EP, de Haan TR, Kroes AC, Beersma MF, Oepkes SD, Walther FJ. Parvovirus B19 infection in pregnancy. J Clinical Virol 2006; 36:1-7.
106. Yaegashi N. Pathogenesis of nonimmune hydrops fetalis caused by intrauterine B19 infection. Tohoku J Exp Med 2000;190:65-82.
107. Doyle S, Kerr S, O'Keefe G, O'Carroll D, Daly C, Kilty P. Detection of parvovirus B19 IgM by antibody capture enzyme immunoassay: receiver operating characteristic analysis. J Virol Methods 2000;90:143-52.
108. de Haan TR, Beerma MF, Oepkes D, dejong EP, Kroes AC, Walther FJ. Parvovirus B19 infection in pregnancy: maternal and fetal viral load measurements related to clinical parameters. Prenat Diag 2007:27:46-50.
109. Cosmi E, Mari G, Delle Chiaie LD, Detti L, Akiyama M, Murphy J et al. Noninvasive diagnosis by doppler ultrasonography of fetal anemia resulting from parvovirus infection. Am J Obstet Gynecol 2002;187:1290-3.
110. Nagel HTC, Haan TR, Vandenbussche FPHA, Oepkes D, Walther FJ. Long term outcome after fetal transfusion for hydrops associated with parvovirus B19 infection. Obstet Gynecol 2007;109:42-7.
111. Dembinski J, Haverkamp F, Maara H, Hansmann M, Eis-Hubinger AM, Bartmann P. Neurodevelopmental outcome after intrauterine red cell transfusion for parvovirus B19-induced fetal hydrops. BJOG 2002;109:1232-34.
112. Centers for Disease Control and Prevention: Disease Burden from Hepatitis A, B, and C in the United States. CDC Website: http://www.cdc.gov/ncidod/ diseases/hepatitis/resource/dz_burden.htm.
113. th ed. New York, McGraw-Hill, 2001.
114. Khuroo MS, Kamili S. Aetiology, clinical course and outcome of sporadic acute viral hepatitis in pregnancy. J Viral Hepat 2003;10:61-9.
115. Zhang RL, Zeng JS, Zhang HZ. Survey of 34 pregnant women with hepatitis A and their neonates. Chin Med J (Engl) 1990;103:552-5.
116. Zhuang YL. [Acute hepatitis A in pregnancy: a report of 43 cases] Zhonghua Fu Chan Ke Za Zhi 1989;24:136-8.
117. Elinav E, Ben-Dov I, Shapira Y, Daudi N, Adler R, Shouval D, Ackerman Z. Acute Hepatitis A infection in pregnancy is associated with high tates of gestational complications and preterm labor. Gastroenterology 2006;130:1129-34.
118. Urganci N, Arapoglu M, Akyildiz B, Nuhoglu A. Neonatal cholestasis resulting from vertical transmission of hepatitis A infection. Pediatr Infect Dis J 2003;22: 381-2.
119. Leikin E, Lysikiewicz A, Garry D, Tejani N. Intrauterine transmission of hepatitis A virus. Obstet Gynecol 1996;88(4 Pt 2):690-1.
120. Duff B, Duff P. Hepatitis A vaccine: ready for prime time. Obstet Gynecol 1998;91:468-71.
121. CDC. Prevention of Hepatitis A Through Active or Passive Immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR 2006;55(No. RR-07).
122. Lee WM. Hepatitis B virus infection. N Engl J Med 1997; 337:1733.
123. Elisofon SA. Hepatitis B and C in children: current treatment and future strategies. Clin Liver Dis 2006;10:133-48, vii.
124. nd, Miller JM Jr, Summers PR. The effect of hepatitis B antigenemia on pregnancy outcome. Am J Obstet Gynecol 1988;158(3 Pt 1):486-9.
125. Wong S, Chan LY, Yu V, Ho L. Hepatitis B carrier and perinatal outcome in singleton pregnancy. Am J Perinatol 1999;16:485-8.
126. Tse KY, Ho LF, Lao T The impact of maternal HBsAg carrier status on pregnancy outcomes: a case-control study. J Hepatol 2005;43:771-5.
127. Zhang SL, Yue YF, Bai GQ, Shi L, Jiang H. Mechanism of intrauterine infection of hepatitis B virus. World J Gastroenterol 2004;10:437-8.
128. Lin HH, Lee TY, Chen DS, Sung JL, Ohto H, Etoh T, Kawana T, Mizuno M. Transplacental leakage of HBeAg-positive maternal blood as the most likely route in causing intrauterine infection with hepatitis B virus. J Pediatr 1987; 111(6 Pt 1):877-881.
129. Hepatitis in pregnancy. ACOG Educational Bulletin, no. 248. 1998.
130. Lee C, Gong Y, Brok J, Boxall EH, Gluud C. Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers. Cochrane Database of Systematic Reviews 2006, Issue 2. Art. No.: CD004790. DOI:10.1002/14651858. CD004790.pub2.
131. Centers for Disease Control and Prevention. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP); Part 1: Immunization of Infants, Children, and Adolescents. MMWR 2005;54 (No.RR-16).
132. Xu Q, Xiao L, Lu XB, Zhang YX, Cai X. A randomized controlled clinical trial: Interruption of intrauterine transmission of hepatitis B virus infection with HBIG. World J Gastroenterol 2006;12: 3434-3437.
133. Li XM, Shi MF, Yang YB, Shi ZJ, Hou HY, Shen HM, Teng BQ. Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection. World J Gastroenterol. 2004;10:3215-7.
134. Yuan J, Lin J, Xu A, Li H, Hu B, Chen J et al. Antepartum immunoprophylaxis of three doses of hepatitis B immunoglobulin is not effective: a single-centre randomized study. J Viral Hepat 2006;13:597-604.
135. van Zonneveld M, van Nunen AB, Niesters HG, de Man RA, Schalm SW, Janssen HL. Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection. J Viral Hepat 2003;10:294-7.
136. Su GG, Pan KH, Zhao NF, Fang SH, Yang DH, Zhou Y. Efficacy and safety of lamivudine treatment for chronic hepatitis B in pregnancy. World J Gastroenterol 2004;10:910-2.
137. Ko TM, Tseng LH, Chang MH, Chen DS, Hsieh FJ, Chuang SM et al. Amniocentesis in mothers who are hepatitis B virus carriers does not expose the infant to an increased risk of hepatitis B virus infection. Arch Gynecol Obstet 1994;255:25-30.
138. Alexander JM, Ramus R, Jackson G, Sercely B, Wendel GD Jr. Risk of hepatitis B transmission after amniocentesis in chronic hepatitis B carriers. Infect Dis Obstet Gynecol 1999;7:283-6.
139. Hill JB, Sheffield JS, Kim MJ Alexander JM, Sercely B, Wendel GD. Risk of hepatitis B transmission in breastfed infants of chronic hepatitis B carriers. Obstet Gynecol 2002;99:1049-52.